NCT02875574View on ClinicalTrials.gov

Improving the Management of Drug Resistant Tuberculosis in the UK

CompletedOBSERVATIONAL
Enrollment

630

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Tuberculosis
Interventions
DRUG

Any treatment regimen

Treatment regimen used to treat patient once isoniazid resistance known (exposure of interest for cohort study)

OTHER

Bacterial mutation

Resistance, compensatory or other mutation in the infecting strain of Mycobacterium tuberculosis (exposure of interest for nested case-control study)

Trial Locations (1)

NW3 2QG

Royal Free London NHS Foundation Trust, London

All Listed Sponsors
collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

University College, London

OTHER

NCT02875574 - Improving the Management of Drug Resistant Tuberculosis in the UK | Biotech Hunter | Biotech Hunter